Indena’s production site passes FDA inspection
Indena has announced that its French production site in Tours has successfully passed the US FDA inspection, with no FDA-483 issued, as per the EIR (Establishment Inspection Report) received from the Center for Food Safety and Applied Nutrition of the FDA. This confirms that the company meets the new requirements mandated by the FDA Food Safety Modernisation Act (FSMA).
The inspection involved the entire organisation and focused on manufacturing operations, HACCP, sanification, cleaning, recall, complaint and training programme and procedures.
François Mairel, Indena Tours plant director, comments, “We are pleased with the successful outcome of the FDA inspection. The audit covered the manufacturing of important products we are selling to our US customer base, like grape seed, olive polyphenolic and ginkgo biloba extracts, and further confirms our commitment in giving our customers the highest standards of quality.”
Indena Tours had already obtained the following certifications: GMP Certificate from the French Health Ministry – ANSM, HACCP, ISO 14001, Kosher, Halal certificate.
